Cellular microRNA and P bodies modulate host-HIV-1 interactions
| dc.contributor.author | Nathans, Robin S. | |
| dc.contributor.author | Chu, Chia-ying | |
| dc.contributor.author | Serquina, Anna Kristina | |
| dc.contributor.author | Lu, Chih-Chung | |
| dc.contributor.author | Cao, Hong | |
| dc.contributor.author | Rana, Tariq M. | |
| dc.date | 2022-08-11T08:08:53.000 | |
| dc.date.accessioned | 2022-08-23T16:11:02Z | |
| dc.date.available | 2022-08-23T16:11:02Z | |
| dc.date.issued | 2009-06-30 | |
| dc.date.submitted | 2009-07-17 | |
| dc.identifier.citation | Mol Cell. 2009 Jun 26;34(6):696-709. <a href="http://dx.doi.org/10.1016/j.molcel.2009.06.003">Link to article on publisher's site</a> | |
| dc.identifier.issn | 1097-4164 (Electronic) | |
| dc.identifier.doi | 10.1016/j.molcel.2009.06.003 | |
| dc.identifier.pmid | 19560422 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.14038/33073 | |
| dc.description.abstract | MicroRNAs (miRNAs), approximately 22 nt noncoding RNAs, assemble into RNA-induced silencing complexes (RISCs) and localize to cytoplasmic substructures called P bodies. Dictated by base-pair complementarity between miRNA and a target mRNA, miRNAs specifically repress posttranscriptional expression of several mRNAs. Here we report that HIV-1 mRNA interacts with RISC proteins and that disrupting P body structures enhances viral production and infectivity. In HIV-1-infected human T lymphocytes, we identified a highly abundant miRNA, miR-29a, which specifically targets the HIV-1 3'UTR region. Inhibiting miR-29a enhanced HIV-1 viral production and infectivity, whereas expressing a miR-29 mimic suppressed viral replication. We also found that specific miR-29a-HIV-1 mRNA interactions enhance viral mRNA association with RISC and P body proteins. Thus we provide an example of a single host miRNA regulating HIV-1 production and infectivity. These studies highlight the significance of miRNAs and P bodies in modulating host cell interactions with HIV-1 and possibly other viruses. | |
| dc.language.iso | en_US | |
| dc.relation | <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=19560422&dopt=Abstract">Link to Article in PubMed</a> | |
| dc.relation.url | http://dx.doi.org/10.1016/j.molcel.2009.06.003 | |
| dc.subject | MicroRNAs; RNA-Induced Silencing Complex; HIV-1 | |
| dc.subject | Life Sciences | |
| dc.subject | Medicine and Health Sciences | |
| dc.title | Cellular microRNA and P bodies modulate host-HIV-1 interactions | |
| dc.type | Journal Article | |
| dc.source.journaltitle | Molecular cell | |
| dc.source.volume | 34 | |
| dc.source.issue | 6 | |
| dc.identifier.legacycoverpage | https://escholarship.umassmed.edu/gsbs_sp/1619 | |
| dc.identifier.contextkey | 902237 | |
| html.description.abstract | <p>MicroRNAs (miRNAs), approximately 22 nt noncoding RNAs, assemble into RNA-induced silencing complexes (RISCs) and localize to cytoplasmic substructures called P bodies. Dictated by base-pair complementarity between miRNA and a target mRNA, miRNAs specifically repress posttranscriptional expression of several mRNAs. Here we report that HIV-1 mRNA interacts with RISC proteins and that disrupting P body structures enhances viral production and infectivity. In HIV-1-infected human T lymphocytes, we identified a highly abundant miRNA, miR-29a, which specifically targets the HIV-1 3'UTR region. Inhibiting miR-29a enhanced HIV-1 viral production and infectivity, whereas expressing a miR-29 mimic suppressed viral replication. We also found that specific miR-29a-HIV-1 mRNA interactions enhance viral mRNA association with RISC and P body proteins. Thus we provide an example of a single host miRNA regulating HIV-1 production and infectivity. These studies highlight the significance of miRNAs and P bodies in modulating host cell interactions with HIV-1 and possibly other viruses.</p> | |
| dc.identifier.submissionpath | gsbs_sp/1619 | |
| dc.contributor.department | Program in Gene Function and Expression | |
| dc.contributor.department | Department of Biochemistry and Molecular Pharmacology | |
| dc.source.pages | 696-709 |